Dental Partners Bidco Limited - Period Ending 2020-03-31

Dental Partners Bidco Limited - Period Ending 2020-03-31


Dental Partners Bidco Limited 10530145 false 2019-04-01 2020-03-31 2020-03-31 The principal activity of the company is that of a holding company. Digita Accounts Production Advanced 6.24.8820.0 Software true true true true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false 10530145 2019-04-01 2020-03-31 10530145 2020-03-31 10530145 bus:Director6 2020-03-31 10530145 bus:Director7 2020-03-31 10530145 bus:OrdinaryShareClass1 2020-03-31 10530145 bus:Consolidated 2020-03-31 10530145 core:RetainedEarningsAccumulatedLosses 2020-03-31 10530145 core:ShareCapital 2020-03-31 10530145 core:CurrentFinancialInstruments core:WithinOneYear 2020-03-31 10530145 core:Non-currentFinancialInstruments 2020-03-31 10530145 core:Non-currentFinancialInstruments core:AfterOneYear 2020-03-31 10530145 bus:FRS102 2019-04-01 2020-03-31 10530145 bus:Audited 2019-04-01 2020-03-31 10530145 bus:FullAccounts 2019-04-01 2020-03-31 10530145 bus:RegisteredOffice 2019-04-01 2020-03-31 10530145 bus:Director1 2019-04-01 2020-03-31 10530145 bus:Director2 2019-04-01 2020-03-31 10530145 bus:Director6 2019-04-01 2020-03-31 10530145 bus:Director7 2019-04-01 2020-03-31 10530145 bus:OrdinaryShareClass1 2019-04-01 2020-03-31 10530145 bus:Consolidated 2019-04-01 2020-03-31 10530145 bus:PrivateLimitedCompanyLtd 2019-04-01 2020-03-31 10530145 core:RetainedEarningsAccumulatedLosses 2019-04-01 2020-03-31 10530145 core:ShareCapital 2019-04-01 2020-03-31 10530145 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2019-04-01 2020-03-31 10530145 core:Subsidiary1 2019-04-01 2020-03-31 10530145 core:Subsidiary1 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary10 2019-04-01 2020-03-31 10530145 core:Subsidiary10 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary11 2019-04-01 2020-03-31 10530145 core:Subsidiary11 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary12 2019-04-01 2020-03-31 10530145 core:Subsidiary12 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary13 2019-04-01 2020-03-31 10530145 core:Subsidiary13 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary14 2019-04-01 2020-03-31 10530145 core:Subsidiary14 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary15 2019-04-01 2020-03-31 10530145 core:Subsidiary15 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary16 2019-04-01 2020-03-31 10530145 core:Subsidiary16 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary17 2019-04-01 2020-03-31 10530145 core:Subsidiary17 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary18 2019-04-01 2020-03-31 10530145 core:Subsidiary18 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary19 2019-04-01 2020-03-31 10530145 core:Subsidiary19 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary2 2019-04-01 2020-03-31 10530145 core:Subsidiary2 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary20 2019-04-01 2020-03-31 10530145 core:Subsidiary20 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary21 2019-04-01 2020-03-31 10530145 core:Subsidiary21 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary22 2019-04-01 2020-03-31 10530145 core:Subsidiary22 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary23 2019-04-01 2020-03-31 10530145 core:Subsidiary23 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary24 2019-04-01 2020-03-31 10530145 core:Subsidiary24 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary25 2019-04-01 2020-03-31 10530145 core:Subsidiary25 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary26 2019-04-01 2020-03-31 10530145 core:Subsidiary26 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary27 2019-04-01 2020-03-31 10530145 core:Subsidiary27 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary28 2019-04-01 2020-03-31 10530145 core:Subsidiary28 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary29 2019-04-01 2020-03-31 10530145 core:Subsidiary29 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary3 2019-04-01 2020-03-31 10530145 core:Subsidiary3 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary30 2019-04-01 2020-03-31 10530145 core:Subsidiary30 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary31 2019-04-01 2020-03-31 10530145 core:Subsidiary31 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary32 2019-04-01 2020-03-31 10530145 core:Subsidiary32 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary33 2019-04-01 2020-03-31 10530145 core:Subsidiary33 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary34 2019-04-01 2020-03-31 10530145 core:Subsidiary34 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary4 2019-04-01 2020-03-31 10530145 core:Subsidiary4 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary5 2019-04-01 2020-03-31 10530145 core:Subsidiary5 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary6 2019-04-01 2020-03-31 10530145 core:Subsidiary6 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary7 2019-04-01 2020-03-31 10530145 core:Subsidiary7 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary8 2019-04-01 2020-03-31 10530145 core:Subsidiary8 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:Subsidiary9 2019-04-01 2020-03-31 10530145 core:Subsidiary9 countries:AllCountries 2019-04-01 2020-03-31 10530145 core:UKTax 2019-04-01 2020-03-31 10530145 countries:AllCountries 2019-04-01 2020-03-31 10530145 2019-03-31 10530145 core:RetainedEarningsAccumulatedLosses 2019-03-31 10530145 core:ShareCapital 2019-03-31 10530145 2018-04-01 2019-03-31 10530145 2019-03-31 10530145 bus:OrdinaryShareClass1 2019-03-31 10530145 core:RetainedEarningsAccumulatedLosses 2019-03-31 10530145 core:ShareCapital 2019-03-31 10530145 core:CurrentFinancialInstruments core:WithinOneYear 2019-03-31 10530145 core:Non-currentFinancialInstruments 2019-03-31 10530145 core:Non-currentFinancialInstruments core:AfterOneYear 2019-03-31 10530145 core:CostValuation 2019-03-31 10530145 core:RetainedEarningsAccumulatedLosses 2018-04-01 2019-03-31 10530145 core:ShareCapital 2018-04-01 2019-03-31 10530145 core:Subsidiary1 2018-04-01 2019-03-31 10530145 core:Subsidiary10 2018-04-01 2019-03-31 10530145 core:Subsidiary11 2018-04-01 2019-03-31 10530145 core:Subsidiary12 2018-04-01 2019-03-31 10530145 core:Subsidiary13 2018-04-01 2019-03-31 10530145 core:Subsidiary14 2018-04-01 2019-03-31 10530145 core:Subsidiary15 2018-04-01 2019-03-31 10530145 core:Subsidiary16 2018-04-01 2019-03-31 10530145 core:Subsidiary17 2018-04-01 2019-03-31 10530145 core:Subsidiary18 2018-04-01 2019-03-31 10530145 core:Subsidiary19 2018-04-01 2019-03-31 10530145 core:Subsidiary2 2018-04-01 2019-03-31 10530145 core:Subsidiary20 2018-04-01 2019-03-31 10530145 core:Subsidiary21 2018-04-01 2019-03-31 10530145 core:Subsidiary22 2018-04-01 2019-03-31 10530145 core:Subsidiary23 2018-04-01 2019-03-31 10530145 core:Subsidiary24 2018-04-01 2019-03-31 10530145 core:Subsidiary25 2018-04-01 2019-03-31 10530145 core:Subsidiary26 2018-04-01 2019-03-31 10530145 core:Subsidiary27 2018-04-01 2019-03-31 10530145 core:Subsidiary28 2018-04-01 2019-03-31 10530145 core:Subsidiary29 2018-04-01 2019-03-31 10530145 core:Subsidiary3 2018-04-01 2019-03-31 10530145 core:Subsidiary30 2018-04-01 2019-03-31 10530145 core:Subsidiary31 2018-04-01 2019-03-31 10530145 core:Subsidiary32 2018-04-01 2019-03-31 10530145 core:Subsidiary33 2018-04-01 2019-03-31 10530145 core:Subsidiary34 2018-04-01 2019-03-31 10530145 core:Subsidiary4 2018-04-01 2019-03-31 10530145 core:Subsidiary5 2018-04-01 2019-03-31 10530145 core:Subsidiary6 2018-04-01 2019-03-31 10530145 core:Subsidiary7 2018-04-01 2019-03-31 10530145 core:Subsidiary8 2018-04-01 2019-03-31 10530145 core:Subsidiary9 2018-04-01 2019-03-31 10530145 core:UKTax 2018-04-01 2019-03-31 10530145 2018-03-31 10530145 core:RetainedEarningsAccumulatedLosses 2018-03-31 10530145 core:ShareCapital 2018-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10530145

Dental Partners Bidco Limited

Annual Report and Financial Statements

for the Year Ended 31 March 2020

Hazlewoods LLP
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

 

Dental Partners Bidco Limited

Contents

Company Information

1

Directors' Report

2

Strategic Report

3

Statement of Directors' Responsibilities

4

Independent Auditor's Report

5 to 7

Profit and Loss Account

8

Balance Sheet

9

Statement of Changes in Equity

10

Notes to the Financial Statements

11 to 18

 

Dental Partners Bidco Limited

Company Information

Directors

C A Dube

N A Lloyd

N R Osborne

Registered office

1310 Solihull Parkway
Birmingham Business Park
Birmingham
B37 7YB

Auditors

Hazlewoods LLP
Windsor House
Bayshill Road
Cheltenham
GL50 3AT

 

Dental Partners Bidco Limited

Directors' Report for the Year Ended 31 March 2020

The directors present their report and the financial statements for the year ended 31 March 2020.

Directors of the company

The directors who held office during the year were as follows:

C A Dube

N A Lloyd

H L Walker (resigned 28 February 2020)

The following director was appointed after the year end:

N R Osborne (appointed 1 September 2020)

Disclosure of information to the auditors

Each director has taken the steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditors are aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditors are unaware.

Reappointment of auditors

Hazlewoods LLP have expressed their willingness to continue in office.

Approved by the Board on 13 January 2021 and signed on its behalf by:

.........................................
N A Lloyd
Director

 

Dental Partners Bidco Limited

Strategic Report for the Year Ended 31 March 2020

The directors present their strategic report for the year ended 31 March 2020.

Principal activity

The principal activity of the company is that of a holding company.

Fair review of the business

At 31 March 2020, the company had total assets less current liabilities of £69,631,787 (2019 - £38,493,301). The directors consider the financial position at the year end to be satisfactory.

Future developments, principal risks and uncertainties, key performance indicators, financial instruments and going concern are all disclosed in the financial statements of Dental Partners Group Limited as the ultimate parent company.

Approved by the Board on 13 January 2021 and signed on its behalf by:

.........................................
N A Lloyd
Director

 

Dental Partners Bidco Limited

Statement of Directors' Responsibilities

The directors are responsible for preparing the Directors' Report, Strategic Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards has been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Dental Partners Bidco Limited

Independent Auditor's Report to the Members of Dental Partners Bidco Limited

Opinion

We have audited the financial statements of Dental Partners Bidco Limited (the 'company') for the year ended 31 March 2020, which comprise the Profit and Loss Account, Balance Sheet, Statement of Changes in Equity, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the company's affairs as at 31 March 2020 and of its loss for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:

the directors’ use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or

the directors have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the company’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

 

Dental Partners Bidco Limited

Independent Auditor's Report to the Members of Dental Partners Bidco Limited

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors’ remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page 4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

 

Dental Partners Bidco Limited

Independent Auditor's Report to the Members of Dental Partners Bidco Limited

Use of our report
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

......................................
Martin Howard (Senior Statutory Auditor)
For and on behalf of Hazlewoods LLP, Statutory Auditor

Windsor House
Bayshill Road
Cheltenham
GL50 3AT

14 January 2021

 

Dental Partners Bidco Limited

Profit and Loss Account for the Year Ended 31 March 2020

Note

2020
 £

2019
 £

Turnover

-

-

Interest payable and similar charges

5

(5,822,315)

(3,074,956)

Loss before tax

 

(5,822,315)

(3,074,956)

Taxation

7

-

-

Loss for the financial year

 

(5,822,315)

(3,074,956)

The above results were derived from continuing operations.

The company has no other comprehensive income for the year.

 

Dental Partners Bidco Limited

(Registration number: 10530145)
Balance Sheet as at 31 March 2020

Note

2020
 £

2019
 £

Fixed assets

 

Investments

8

11,407,903

11,407,903

Current assets

 

Debtors

9

96,604,517

52,411,629

Creditors: Amounts falling due within one year

10

(38,380,633)

(25,326,231)

Net current assets

 

58,223,884

27,085,398

Total assets less current liabilities

 

69,631,787

38,493,301

Creditors: Amounts falling due after more than one year

10

78,123,726

41,162,925

Capital and reserves

 

Called up share capital

12

405,332

405,332

Profit and loss account

(8,897,271)

(3,074,956)

Total equity

 

(8,491,939)

(2,669,624)

Total capital, reserves and long term liabilities

 

69,631,787

38,493,301

Approved and authorised by the Board on 13 January 2021 and signed on its behalf by:
 

.........................................

N A Lloyd
Director

 

Dental Partners Bidco Limited

Statement of Changes in Equity for the Year Ended 31 March 2020

Share capital
£

Profit and loss account
£

Total
£

At 1 April 2019

405,332

(3,074,956)

(2,669,624)

Loss for the year

-

(5,822,315)

(5,822,315)

At 31 March 2020

405,332

(8,897,271)

(8,491,939)

Share capital
£

Profit and loss account
£

Total
£

At 1 April 2018

405,332

-

405,332

Loss for the year

-

(3,074,956)

(3,074,956)

At 31 March 2019

405,332

(3,074,956)

(2,669,624)

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2020

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
1310 Solihull Parkway
Birmingham Business Park
Birmingham
B37 7YB

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Summary of disclosure exemptions

The company has not presented a cash flow statement on the grounds that the company is a wholly owned subsidiary and a group cash flow statement is included in the financial statements of the ultimate parent company.

Name of parent of group

These financial statements are consolidated in the financial statements of Dental Partners Group Limited.

The financial statements of Dental Partners Group Limited may be obtained from Companies House.

Group accounts not prepared

The financial statements present information about the company as an individual undertaking and not about its group. The company has not prepared group accounts as it is exempt from the requirements to do so by section 400 of the Companies Act 2006 as it is a subsidiary undertaking of Dental Partners Group Limited, a company incorporated in England and Wales, and is included in the consolidated accounts of that company.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or estimation uncertainty.

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2020

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2020

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2020

 

3

Staff costs

The average number of persons employed by the company (including directors) during the year, analysed by category was as follows:

2020
 No.

2019
 No.

Directors

3

3

 

4

Directors' remuneration

The directors' remuneration for the year was borne by a fellow group undertaking.

 

5

Interest payable and similar expenses

2020
£

2019
£

Bank loan interest payable

5,597,216

2,697,331

Finance costs adjacent to interest

225,099

377,625

5,822,315

3,074,956

 

6

Auditors' remuneration

Audit fees for the year have been borne by a fellow group undertaking.

 

7

Taxation

The tax on profit before tax for the year is higher than the standard rate of corporation tax in the UK (2019 - higher than the standard rate of corporation tax in the UK) of 19% (2019 - 19%).

The differences are reconciled below:

2020
£

2019
£

Loss before tax

(5,822,315)

(3,074,956)

Corporation tax at standard rate

(1,106,240)

(584,242)

Effect of expense not deductible in determining taxable profit (tax loss)

246,402

-

Deferred tax credit relating to changes in tax rates or laws

(11,550)

-

Increase from tax losses for which no deferred tax asset was recognised

217,572

-

Tax increase arising from group relief

653,816

584,242

Total tax charge/(credit)

-

-

 

8

Investments in subsidiaries, joint ventures and associates

2020
£

2019
£

Investments in subsidiaries

11,407,903

11,407,903

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2020

Subsidiaries

£

Cost and carrying amount

At 1 April 2019 and at 31 March 2020

11,407,903

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2020

Details of undertakings

Details of the investments in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

     

2020

2019

Subsidiary undertakings

Dental Partners Holdings Limited *

Ordinary

100%

100%

 

England and Wales

     

Dental Partners Trading Limited **

Ordinary

100%

100%

 

England and Wales

     

Genesis CDA Limited ***

Ordinary

100%

100%

 

England and Wales

     

Lincoln CDA Limited **

Ordinary

100%

100%

 

England and Wales

     

Dental Partners (DISA) Limited **

Ordinary

100%

100%

 

England and Wales

     

Yorkshire And Humberside CDA Limited **

Ordinary

100%

100%

 

England and Wales

     

Taptonville House Limited **

Ordinary

100%

100%

 

England and Wales

     

Marhall Holdings Limited ***

Ordinary

100%

100%

 

England and Wales

     

Humber And Yorkshire CDA Limited **

Ordinary

100%

100%

 

England and Wales

     

HC 1287 Limited ***

Ordinary

100%

100%

 

England and Wales

     

Hurlfield Limited **

Ordinary

100%

100%

 

England and Wales

     

Newtown (No 1) Limited **

Ordinary

100%

100%

 

England and Wales

     

Dentapol Limited **

Ordinary

100%

100%

 

England and Wales

     

Kaye And Rafferty Limited **

Ordinary

100%

100%

 

England and Wales

     

Prime Dental Care Limited **

Ordinary

100%

100%

 

England and Wales

     

Wickersley Dental Practice Limited **

Ordinary

100%

0%

 

England and Wales

     

McDaid Dental Care Limited **

Ordinary

100%

0%

 

England and Wales

     

Ravat & Ray Holdings Limited **

Ordinary

100%

0%

 

England and Wales

     

Ravat and Ray Dental Care (Chadderton) Limited **

Ordinary

100%

0%

 

England and Wales

     

Ravat and Ray Dental Care (Chorley) Limited **

Ordinary

100%

0%

 

England and Wales

     

Ravat and Ray Dental Care (Bradford) Limited **

Ordinary

100%

0%

 

England and Wales

     

Ravat and Ray Dental Care (Burnley) Limited **

Ordinary

100%

0%

 

England and Wales

     

Ravat and Ray Dental Care (Fitton Hill) Limited **

Ordinary

100%

0%

 

England and Wales

     

Ravat and Ray Dental Care (Ormskirk) Limited **

Ordinary

100%

0%

 

England and Wales

     

Ravat and Ray Dental Care (Salford) Limited **

Ordinary

100%

0%

 

England and Wales

     

Ravat and Ray Dental Care (Wigan) Limited **

Ordinary

100%

0%

 

England and Wales

     

Highfield Dental Practice Limited **

Ordinary

100%

0%

 

England and Wales

     

Greater Manchester Dental Alliance Limited **

Ordinary

100%

0%

 

England and Wales

     

Greater Manchester Dental Alliance (NE) Limited **

Ordinary

100%

0%

 

England and Wales

     

Dental Sense Limited **

Ordinary

100%

0%

 

England and Wales

     

Dental Partners Morley Limited **

Ordinary

100%

0%

 

England and Wales

     

Dental Partners Kiveton Limited **

Ordinary

100%

0%

 

England and Wales

     

Dental Partners Conisborough Limited **

Ordinary

100%

0%

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2020

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

 

England and Wales

     

DA Clinics Limited **

Ordinary

100%

0%

 

England and Wales

     

* - The principal activity is as a holding company.
** - The principal activity is the provision of dental services.
*** - The principal activity is as a dormant company.

Dental Partners Holdings Limited is held directly. All other companies are held indirectly.

 

9

Debtors

2020
 £

2019
 £

Amounts owed by group undertakings

96,604,517

52,411,629

 

10

Creditors

2020
 £

2019
 £

Due within one year

Amounts due to group undertakings

36,106,020

25,326,231

Accrued expenses

2,274,613

-

38,380,633

25,326,231

Due after one year

Loans and borrowings

78,123,726

41,162,925

 

11

Loans and borrowings

2020
£

2019
£

Non-current loans and borrowings

Bank borrowings

78,123,726

41,162,925

Total bank loans outstanding of £78,123,726 (2019 - £41,162,925) include accrued interest of £1,181,277 (after deducting £2,494,551 (2019 - £2,112,075) of costs associated with the raising of this finance which are being released to the profit and loss account over the term of the debt; i.e. total bank debt was £79,437,000 (2019 - £43,275,000) at 31 March 2020) are repayable in a lump sum on 11 April 2024. Interest is levied at a rate of 7.5-12% over LIBOR per annum, subject to the group's compliance with banking covenants.

The group has entered into an interest rate cap agreement with its bankers in respect of £41,200,000 of the bank loan. The interest rate applicable to the hedged loan is a 1.25% - 1.75% cap on LIBOR.

 

Dental Partners Bidco Limited

Notes to the Financial Statements for the Year Ended 31 March 2020

 

12

Share capital

Allotted, called up and fully paid shares

 

2020

2019

 

No.

£

No.

£

Ordinary shares of £1 each

405,332

405,332

405,332

405,332

         
 

13

Related party transactions

Summary of transactions with key management

Key management personnel are considered to be the directors of the company and key management personnel compensation is disclosed in note 4 to the financial statements.

 

14

Parent and ultimate parent undertaking

The company's immediate parent undertaking is Dental Partners Finco Limited and the ultimate parent undertaking is Dental Partners Group Limited, both registered in England and Wales.

The ultimate controlling party is August Equity LLP, an entity registered in England and Wales, which is considered to have no single controlling party.